f Glutathione-responsive Nanoparticles for Optimized Cas9/sgRNA Gene Editing Delivery

References

1. LiuF. MaF. WangY. PKM2 methylation by CARM1 activates aerobic glycolysis to promote tumorigenesis.Nat. Cell Biol.201719111358137010.1038/ncb3630 29058718
   [Google Scholar]
2. MaqboolM. HussainM.S. ShaikhN.K. SultanaA. BishtA.S. AgrawalM. Noncoding RNAs in the COVID-19 Saga: An untold story.Viral Immunol.202437626928610.1089/vim.2024.0026 38968365
   [Google Scholar]
3. XieF. WangM. ChenQ. Endogenous stimuli-responsive nanoparticles for cancer therapy: From bench to bedside.Pharmacol. Res.202218610652210.1016/j.phrs.2022.106522 36283629
   [Google Scholar]
4. WangM. ZurisJ.A. MengF. Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.Proc. Natl. Acad. Sci. USA2016113112868287310.1073/pnas.1520244113 26929348
   [Google Scholar]
5. LiuJ ChangJ JiangY MengX SunT MaoL. Fast and efficient CRISPR/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles. Adv Mater 201931e190257510.1002/adma.201902575
   [Google Scholar]
6. ChenG. MaB. WangY. GongS. A universal GSH-responsive nanoplatform for the delivery of DNA, mRNA, and Cas9/sgRNA ribonucleoprotein.ACS Appl. Mater. Interfaces20181022185151852310.1021/acsami.8b03496 29798662
   [Google Scholar]
7. ChenG. AbdeenA.A. WangY. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.Nat. Nanotechnol.2019141097498010.1038/s41565‑019‑0539‑2 31501532
   [Google Scholar]
8. KhanY. HussainM.S. RamalingamP.S. Exploring extracellular RNA as drivers of chemotherapy resistance in cancer.Mol. Biol. Rep.202552114210.1007/s11033‑025‑10263‑2 39836259
   [Google Scholar]
9. LingX. TuJ. WangJ. Glutathione-responsive prodrug nanoparticles for effective drug delivery and cancer therapy.ACS Nano201913135737010.1021/acsnano.8b06400 30485068
   [Google Scholar]
10. DingH. ZhouC. LiT. Nanomedicines with Versatile GSH-responsive linkers for cancer theranostics.ACS Biomater. Sci. Eng.202410105977599410.1021/acsbiomaterials.4c00897 39298132
    [Google Scholar]
11. HussainS. GuptaG. ShahwanM. Non-coding RNA: A key regulator in the Glutathione-GPX4 pathway of ferroptosis.Noncoding RNA Res.2024941222123410.1016/j.ncrna.2024.05.007 39036600
    [Google Scholar]
12. SahelDK VoraLK SaraswatA SharmaS MonparaJ D'SouzaAA CRISPR/Cas9 genome editing for tissue-specific in vivo targeting: Nanomaterials and translational perspective. Adv Sci (Weinh) 20231019e220751210.1002/advs.202207512
    [Google Scholar]
13. HuangS. XuZ. ZhiW. pH/GSH dual-responsive nanoparticle for auto-amplified tumor therapy of breast cancer.J. Nanobiotechnology202422132410.1186/s12951‑024‑02588‑0 38858692
    [Google Scholar]
14. YuanY. NieT. FangY. YouX. HuangH. WuJ. Stimuli-responsive cyclodextrin-based supramolecular assemblies as drug carriers.J. Mater. Chem. B Mater. Biol. Med.202210132077209610.1039/D1TB02683F 35233592
    [Google Scholar]
15. HuangY. Moini JazaniA. HowellE.P. OhJ.K. MoffittM.G. Controlled microfluidic synthesis of biological stimuli-responsive polymer nanoparticles.ACS Appl. Mater. Interfaces202012117719010.1021/acsami.9b17101 31820915
    [Google Scholar]
16. SuH. RongG. LiL. ChengY. Subcellular targeting strategies for protein and peptide delivery.Adv. Drug Deliv. Rev.202421211538710.1016/j.addr.2024.115387 38964543
    [Google Scholar]
17. IqbalZ. RehmanK. XiaJ. Biomaterial-assisted targeted and controlled delivery of CRISPR/Cas9 for precise gene editing.Biomater. Sci.202311113762378310.1039/D2BM01636B 37102700
    [Google Scholar]
18. ClealK. HeL. WatsonP.D. JonesA.T. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles.Curr. Pharm. Des.201319162878289410.2174/13816128113199990297 23140451
    [Google Scholar]